Packaging & Product Protection White Papers & Case Studies

  1. Gain Greater Flexibility In Pharma Packaging

    In numerous pharma compa­nies, the following problem is being posed: shrinking lot sizes are constantly worsening the ratio of packaging system set-up time to running time. By Dr. Ralph Blum, Mediseal GmbH, Schloss Holte

  2. Late Stage Customization For Small Lots Of Blister Packaging

    Two years ago, Elaiapharm undertook the packaging of an important new solid dose product (Cipralex, an antidepressant) to be launched across a large number of international markets. The product itself is an ODT – orally dispersible tablet – formulation packed in child resistant cold form blisters.

  3. Autoclavable PP Blisters With Filled Disposable Syringes

    At the end of the packaging process, the packaged syringes should meet the requirements for sterile devices in the operating room. Therefore, the finished blisters are autoclaved at 121 °C (2 bar) for 15 minutes. Only minimal deformation of the blisters is tolerated, so that the syringes can be used in the operating room without problems after this thermal treatment.

  4. 2 Sachet Machines Connected To 1 Cartoner

    Volumetric feeding by means of a flowmeter, a method that has become established at Pharmatis, was also implemented in this project; the configuration was taken over by the Mediseal HMI. The feeding system is highly flexible and can be adapted to a wide range of products.

  5. Contract Packaging Organization Install Track & Trace System To Meet Serialization Requirements

    Millmount Healthcare, a world-leading Health Products Regulatory Authorized Organization, specialize in pharmaceutical and healthcare blister and bottle/tub contract packaging. Millmount pride themselves on attention to detail and strict punctuality to fit stringent production requirements. Millmount found themselves in need of user-friendly, compact TQS solution capable of combining precise weighing with reliable serialisation of packaged products. The OCS Traceable Quality System represents a unique solution that combines all the future global Track & Trace requirements in one single system, intuitive and very easy to operate.

  6. Pharma Manufacturer Installs '4-In-1 System' For Serialization, Weighing And Sealing

    The medium-sized pharmaceuticals company Krewel Meuselbach GmbH manufactures top-quality, affordable pharmaceuticals at its Eitorf (North Rhine-Westphalia) and Gehren (Thuringia) sites in Germany, using state-of-the art technology.

  7. Modular Pharmaceutical Packaging Equipment From A Single Source

    Pharmaceutical producers naturally want to utilize their machine capacities to the fullest in day-to-day business. The key words read efficiency, reliability and flexibility – all in line with the highest safety and cGMP standards. Modern and flexible equipment plays a major role in achieving maximum uptime and high quality in all packaging processes. “We always bear in mind our customer’s demands when developing new equipment or designing tailor-made line concepts. This is why all our machines and components are based on a modular concept,” Ralph Pfister, area sales manager at Bosch Packaging Technology, underlines.

  8. Handling And Packaging Of Blow Fill Seal Vials With Liquid Eye Drops

    Specializing in sterile manufacturing, Excelvision, based in Annonay, France, provides contract manufacturing services for liquid eye drop plastic vials to numerous companies. However, to increase production and capitalize on additional contract manufacturing opportunities, Excelvision enlised Bosch Packaging Systems AG, based in Beringen, Switzerland, to install a fully automated packaging line. With significantly higher output capabilities, Excelvision expects to increase production by nearly five-fold. The new line also gives the company greater flexibility to meet the diverse requirements of its customers.

  9. Ensure Tamper-Evident Pharmaceutical Packaging For EU Compliance

    Falsified medicines are fake medicines that pass themselves off as real, authorized medicines. They may contain ineffective or incorrect doses of active ingredients and pose a major threat to public health and safety. As falsifications become more sophisticated, the risk of falsified medicines reaching patients in the EU increases every year. Not only do falsified medicines present an incalculable health risk for patients, they also damage the corporate image of pharmaceutical manufacturers and can lead to large financial losses.

  10. Countdown To The 2017 DSCSA Deadline: Serialization Strategies For Compliance

    The next milestone for manufacturers, November 27, 2017, is the date by which pharmaceutical manufacturers are required to print a unique product identification code on all Rx units of sale and homogenous cases distributed domestically.